Tuesday, March 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense News Headlines of the Week – September 7, 2014

by Global Biodefense Staff
September 7, 2014

Global Biodefense News Headlines LogoEbola vaccination: If not now, when? | Johnson & Johnson pushes ahead with Ebola vaccine | U.S. Southern Command Shows off new disaster relief technology | Gamers helping UW in Ebola research | WHO on Ebola: Blood may offer help now, vaccines this fall | NIH finds old ricin, deadly germs forgotten in labs | Make haste on experimental Ebola treatments, urges WHO | Cuts at WHO hurt response to Ebola crisis | Strong new pathogen standards would save lives | First vaccine for dengue fever shows promise in 2nd big trial | Use of untested drugs for Ebola should be limited to best candidates | Pentagon: Website improves communication between DoD, industry | Medical registry systems becoming part of emergency preparedness plans | Approaches to eliminate HIV and opportunistic pathogens from oral reservoirs | Experimental Ebola drug ZMapp shows promise | A better flu shot | US to provide $75M to expand Ebola care centers | Military Health System protects global health, official says | Study identifies protein that helps prevent active TB in infected patients

See what we’re reading this week at Global Biodefense on the push for Ebola vaccines, debate on food pathogen standards and more…

Ebola vaccination: If not now, when? (Annals of Internal Medicine)

Johnson & Johnson pushes ahead with Ebola vaccine (NPR)

U.S. Southern Command Shows off new disaster relief technology (EM)

Gamers helping UW in Ebola research (Seattle Times)

WHO on Ebola: Blood may offer help now, vaccines this fall (CIDRAP)

NIH finds old ricin, deadly germs forgotten in labs (Seattle Times)

Make haste on experimental Ebola treatments, urges WHO (Science)

Cuts at WHO hurt response to Ebola crisis (NY Times)

Strong new pathogen standards would save lives (Food Safety News)

First vaccine for dengue fever shows promise in 2nd big trial (NY Times)

Use of untested drugs for Ebola should be limited to best candidates (Daily Courier)

Pentagon: Website improves communication between DoD, industry (DefenseNews)

Medical registry systems becoming part of emergency preparedness plans (HSNW)

Approaches to eliminate HIV and opportunistic pathogens from oral reservoirs (NIH)

Experimental Ebola drug ZMapp shows promise (The Scientist)

A better flu shot (NY Times)

US to provide $75M to expand Ebola care centers (Seattle Times)

Military Health System protects global health, official says (DoD)

Study identifies protein that helps prevent active TB in infected patients (UCLA)

Tags: EbolaInfluenzaRicin

Related Posts

News Scan

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023
News Scan

Biodefense Headlines – 12 March 2023

March 12, 2023
Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC